Atara Biotherapeutics, Inc. 10-Q filing
Filed 2025-08-11 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-106550
- Form type
- 10-Q
- CIK
- 0001604464
- Primary document
- https://www.sec.gov/Archives/edgar/data/1604464/000095017025106550/atra-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Atara Biotherapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $115.7M | - | - |
| Operating Income | $42.0M | - | - |
| Net Income | $40.4M | - | - |
| Eps Basic | 3.52 | - | - |
| Eps Diluted | 3.49 | - | - |
| Cash And Equivalents | $16.9M | - | - |
| Total Assets | $36.9M | - | - |
| Total Liabilities | $71.9M | - | - |
| Shareholders Equity | $-35.0M | - | - |
| Operating Cash Flow | $-35.5M | - | - |
| Capital Expenditures | $0 | - | - |